Fructose-induced metabolic syndrome has been partially inhibited by treatment with xanthine oxidase inhibitors [20,97], with a documented reduction in the occurrence of fructose-mediated fatty liver [98]. This evidence concerns the gene XDH and metabolic syndrome.